US Earnings Financial Results SEC Filings — September 02, 2026

02-09-2026

Ollie's Bargain Outlet Holdings reported strong Q2 FY2026 results with net income of $85.5M for the thirteen weeks ended August 1, 2026, up 39.4% from $61.3M a year earlier. Revenue grew 9.1% to $741.3M driven by a 18.7% gross profit expansion. However, operating cash flow declined slightly and the company used $137.3M to repurchase shares, bringing cash and equivalents down to $120.8M from $259.7M at year-start.

• · Diluted EPS for Q2 was $1.42 vs $0.99 a year ago, an increase of 43.4%.
• · Selling, general, and administrative expenses rose to $197.2M from $175.5M in Q2, an increase of 12.4%.
• · Pre-opening expenses declined to $5.2M in Q2 from $9.0M in the prior year period.
• · The company spent $137.3M on share repurchases in the first half of 2026, compared to $28.6M in the first half of 2025.
• · Cash and cash equivalents dropped to $120.8M from $259.7M at year start, a decline of 53.5%.
• · Inventories grew to $704.4M from $650.3M at year start (up 8.3%) and from $637.2M a year ago (up 10.5%).
• · Total assets increased to $3.03B from $2.95B at year start and $2.80B a year ago.
• · Total liabilities rose to $1.13B from $1.07B at year start and $1.02B a year ago.

02-09-2026

GitLab Inc. reported total revenue of $286.3M for Q2 FY27 (three months ended July 31, 2026), up 21.3% YoY from $236.0M, driven by subscription revenue growth of 21.5% to $258.3M. However, net loss attributable to GitLab widened significantly to $36.8M from $9.2M in the prior-year quarter, as operating expenses rose 31.8% to $297.6M, outpacing revenue growth. The company also repurchased $105.3M of common stock during the quarter, reducing total stockholders' equity to $971.5M from $1,036.2M at year-end.

• · Gross profit for Q2 FY27 was $240.6M, up 16.0% from $207.5M in Q2 FY26.
• · Sales and marketing expenses for Q2 FY27 were $134.4M, up 22.6% YoY.
• · Research and development expenses for Q2 FY27 were $95.0M, up 32.9% YoY.
• · General and administrative expenses for Q2 FY27 were $68.2M, up 52.5% YoY.
• · Interest income for Q2 FY27 was $12.2M, up 6.0% from $11.5M.
• · Other income (expense), net swung to income of $5.4M from expense of $0.9M.
• · Provision for income taxes was a benefit of $3.2M vs expense of $2.2M in prior year.
• · Deferred revenue (current) increased to $553.8M from $545.1M at year-end.
• · Accounts receivable decreased to $257.3M from $304.3M at year-end.
• · Accumulated deficit grew to $1,265.4M from $1,223.6M at year-end.
• · Noncontrolling interests were $46.0M as of July 31, 2026.

02-09-2026

FuelCell Energy reported a net loss of $45.3M for Q3 FY2026, a significant improvement from the $91.9M loss in Q3 FY2025, driven by the absence of a $64.5M impairment charge. However, total revenues fell 29% YoY to $33.0M, with declines across all segments, and the company posted a gross loss of $24.5M, widening from a $5.1M gross loss a year ago.

• · Product cost of revenues surged 27.6% YoY to $37.1M in Q3, contributing to a gross loss of $24.5M vs. $5.1M a year ago.
• · The company recorded a $42.6M impairment expense in the nine months ended July 31, 2026, compared to $64.5M in the prior period.
• · Cash and cash equivalents (unrestricted) more than doubled to $658.1M as of July 31, 2026, from $278.1M at October 31, 2025, driven by significant equity issuances.
• · Total assets grew 40.7% to $1.31B, while total liabilities increased 33.5% to $268.4M.
• · Weighted average shares outstanding increased 188% YoY in Q3, reflecting substantial dilution from stock sales.

02-09-2026

Keysight Technologies reported strong Q3 FY2026 results with total revenue of $1,846M, up 36.5% YoY from $1,352M, driven by product revenue growth of 43.1% to $1,464M. Net income more than doubled to $397M from $191M, with diluted EPS rising to $2.30 from $1.10. However, the company's other comprehensive income swung to a loss of $22M from a loss of $2M in the prior-year quarter, and cash flow from operations increased but at a slower pace relative to revenue growth.

• · Total assets increased to $11,921M as of July 31, 2026 from $11,301M as of October 31, 2025.
• · Cash and cash equivalents rose to $2,605M from $1,873M over the same period.
• · Long-term debt decreased to $1,817M from $2,534M, while current portion of long-term debt increased to $700M from $0.
• · Goodwill increased to $3,462M from $3,424M, and other intangible assets decreased to $1,113M from $1,304M.
• · The company completed an acquisition on October 15, 2025 with total consideration of $1,564M, including $1,415M cash consideration and $712M goodwill.
• · Treasury stock repurchases for the nine months ended July 31, 2026 were $520M, up from $278M in the prior year period.
• · Interest income declined 35.5% YoY in Q3 to $20M, and 23.9% for the nine-month period.
• · Other comprehensive income (loss) worsened to a loss of $22M in Q3 FY2026 from a loss of $2M in Q3 FY2025, primarily due to foreign currency translation losses.
• · Provision for income taxes for the nine months decreased 53.8% to $66M from $143M, despite higher pre-tax income.

02-09-2026

Brown-Forman Corp reported net income of $176M for the three months ended July 31, 2026, up from $170M in the prior-year period, a 3.5% increase. However, comprehensive income fell to $160M from $206M due to negative currency translation adjustments of ($23M) versus positive $25M a year ago. Total assets decreased slightly to $7,825M from $7,894M, while cash and cash equivalents declined to $301M from $308M, and the company repaid $343M in long-term debt, reducing total debt to $2,083M.

• · Diluted earnings per share increased to $0.38 from $0.36 year-over-year.
• · Cash provided by operating activities rose to $173M from $160M.
• · The company repaid $343M in long-term debt during the quarter, eliminating the current portion of long-term debt.
• · Short-term borrowings increased to $358M from $68M at April 30, 2026.
• · Restructuring charges were $0 in Q1 FY2026 compared to $12M in Q1 FY2025.
• · Goodwill decreased by $9M due to foreign currency translation adjustments.
• · Total inventories increased to $2,574M from $2,543M, driven by higher finished goods and work in process.
• · Accounts payable and accrued expenses decreased to $700M from $795M.

02-09-2026

NetApp reported strong Q1 FY27 results with net revenues of $2,025M, up 29.9% YoY from $1,559M, driven by product revenue growth of 50.9% to $987M and services revenue growth of 14.7% to $1,038M. Net income rose 60.9% to $375M from $233M, with diluted EPS increasing to $1.88 from $1.15. However, operating cash flow declined 25.3% to $503M from $673M, and the company recorded $56M in restructuring charges versus $2M a year ago. Cash and cash equivalents fell to $1,573M from $2,070M at the prior quarter end, partly due to $200M in share repurchases and a $78M business acquisition.

• · Gross profit rose to $1,419M from $1,098M, with gross margin improving to 70.1% from 70.4%.
• · Operating expenses increased 18.5% to $935M from $789M, driven by a surge in restructuring charges.
• · Income from operations grew 56.6% to $484M from $309M.
• · The company acquired a business for $78M in cash, with total purchase price of $193M including $151M goodwill and $22M developed technology.
• · Dividends paid were $102M ($0.52 per share), consistent with prior year's $104M.
• · Short-term investments increased to $2,003M from $1,514M, while accounts receivable decreased to $966M from $1,286M.
• · Inventories rose to $375M from $198M, contributing to negative working capital change in cash flow.
• · Current portion of long-term debt increased to $550M from $0, while long-term debt decreased to $1,938M from $2,487M.
• · Accumulated other comprehensive loss widened to $(21)M from $(11)M due to foreign currency translation losses.
• · Basic shares outstanding declined to 196M from 201M due to share repurchases.

02-09-2026

Southern Cross Acquisition I Corp. filed its 10-Q for the quarter ended June 30, 2026, reporting a net loss of $19,738 for the three-month period and $84,023 for the six-month period, compared to zero net loss in the prior-year period (inception to June 30, 2025). Cash decreased 41.1% from $346,015 at December 31, 2025 to $203,861, while total assets fell 13.9% to $420,992. The company's accumulated deficit widened to ($89,308) from ($5,285), resulting in a negative shareholders' equity of ($64,308) versus positive equity of $19,715 at year-end 2025.

• · The company had no revenue and incurred $84,023 in formation and operating costs for the six months ended June 30, 2026.
• · Net cash used in operating activities was $122,143 for the six-month period.
• · Deferred offering costs increased to $217,131 from $100,000 at year-end 2025.
• · The company had a promissory note of $469,300 to a related party, unchanged from December 31, 2025.
• · No ordinary shares were issued or repurchased during the period; shares outstanding remained at 2,875,000.
• · Basic and diluted net loss per ordinary share was ($0.01) for the quarter and ($0.03) for the six-month period.

02-09-2026

Scribe Therapeutics reported a net loss of $6.5M for Q2 2026 (improved from $9.9M loss in Q2 2025) and $23.8M for H1 2026 (wider than $13.3M loss in H1 2025). Collaboration revenue declined sharply to $1.9M in Q2 2026 from $4.9M in Q2 2025, and to $4.2M in H1 2026 from $22.0M in H1 2025. Operating expenses fell 32% in Q2 and 34% in H1, but the company's accumulated deficit grew to $181.5M and total stockholders' deficit reached $164.8M.

• · Prevail accounted for 100% of accounts receivable as of June 30, 2026 and 98% as of December 31, 2025, and 100% of revenue for Q2 2026 and 98% for Q2 2025.
• · Net cash used in operating activities improved to $12.9M in H1 2026 from $20.3M in H1 2025.
• · Cash provided by investing activities was $37.5M in H1 2026 vs $23.6M in H1 2025, driven by maturities of investments.
• · The company received $3.8M in government grants in H1 2026, compared to $0 in H1 2025.
• · Stock-based compensation expense increased to $2.2M in H1 2026 from $1.3M in H1 2025.
• · Deferred revenue (current and non-current) totaled $39.2M as of June 30, 2026, down from $41.0M as of December 31, 2025.
• · The Convertible Note's fair value change contributed a $3.0M gain in Q2 2026 vs a $0.7M gain in Q2 2025, but a $1.6M loss in H1 2026 vs a $2.1M gain in H1 2025.
• · Weighted-average shares used in net loss per share increased to 2,475,898 in Q2 2026 from 2,429,130 in Q2 2025.

02-09-2026

Methode Electronics reported a net loss of $11.4M for Q1 FY27 (13 weeks ended August 1, 2026), widening from a $10.3M loss in the prior-year quarter. While net sales grew 10.4% to $265.4M, the company swung to an operating loss of $3.9M from operating income of $1.1M a year ago, driven by a sharp increase in selling and administrative expenses. Cash flow from operations turned negative at -$7.8M versus $25.1M in the prior period, and the company ended the quarter with $116.2M in cash, down from $139.6M at the start of the period.

• · Net sales by segment: Automotive $105.7M, Industrial $156.8M, Interface $2.9M.
• · Geographic net sales: North America $115.8M, EMEA $112.9M, Asia $36.7M.
• · Amortization of intangibles was $5.7M (Q1 FY27) vs $5.8M (Q1 FY26).
• · Interest expense, net was $5.2M (Q1 FY27) vs $5.9M (Q1 FY26).
• · Income tax expense was $4.1M (Q1 FY27) vs $4.2M (Q1 FY26).
• · Basic and diluted loss per share: $(0.32) (Q1 FY27) vs $(0.29) (Q1 FY26).
• · Cash dividends per share reduced to $0.05 (Q1 FY27) from $0.07 (Q1 FY26).
• · Total assets decreased to $1,263.7M from $1,306.1M (May 2, 2026).
• · Total liabilities decreased to $600.6M from $628.6M (May 2, 2026).
• · Capital expenditures (purchases of PP&E) were $3.1M (Q1 FY27) vs $7.1M (Q1 FY26).
• · Proceeds from borrowings were $10.0M (Q1 FY27) vs $78.5M (Q1 FY26); repayments were $20.1M vs $78.1M.
• · Foreign currency translation adjustment was a loss of $3.0M (Q1 FY27) vs a gain of $6.3M (Q1 FY26).

02-09-2026

Credo Technology Group reported a strong Q1 FY27 with revenue surging 114.7% YoY to $479.0M and net income doubling to $129.4M, driven by robust demand and a recent acquisition. However, cash and cash equivalents plummeted 59.9% from $1.16B to $466.9M, primarily due to $735.6M in cash used for a business acquisition. The company also issued $169.1M in shares and recorded $300.0M in contingent consideration related to the acquisition.

• · Total assets increased 31.2% from $2.30B to $3.01B, driven by $895.8M in new goodwill and $361.7M in intangible assets from the acquisition.
• · Operating cash flow improved 66.5% YoY to $90.2M, but investing cash flow was a negative $762.0M due to the acquisition.
• · The company's effective tax rate was negative due to a $585K tax benefit, compared to a $1.3M provision in the prior year.
• · Accumulated other comprehensive income swung from a gain of $2.4M to a loss of $138K, primarily due to a foreign currency translation loss of $2.6M.
• · Total shareholders' equity grew 32.2% from $2.06B to $2.73B, supported by the acquisition-related share issuance and retained earnings.

02-09-2026

ARGAN INC (AGX) reported strong financial results for the three and six months ended July 31, 2026, with revenues surging 61.5% to $384.0M in Q2 and 56.5% to $674.9M in the first half, driven by robust growth across all geographic segments. Net income rose 51.1% to $53.3M in Q2 and 71.8% to $99.4M in the first half, while cash flow from operations tripled to $210.4M. However, the company recorded net unrealized losses on available-for-sale securities of $4.6M in Q2 and $7.2M in the first half, and foreign currency translation losses of $0.3M and $0.8M, respectively, partially offsetting comprehensive income.

• · Total assets increased 18.1% to $1.40B at July 31, 2026 from $1.19B at January 31, 2026.
• · Total liabilities rose 23.5% to $894.1M from $724.1M, primarily due to a $113.1M increase in contract liabilities.
• · Stockholders' equity grew 9.6% to $506.8M from $462.3M, supported by retained earnings of $491.5M.
• · The company completed an acquisition for $8.0M (net of cash acquired) during H1 FY26, issuing 877 shares of treasury stock as part of the consideration.
• · Intangible assets, net increased to $6.0M from $1.5M, reflecting the addition of $4.7M in customer relationships from the acquisition.
• · Right-of-use assets increased to $23.0M from $8.0M, with $19.0M in new lease obligations obtained during H1 FY26.
• · Cash used in investing activities was $130.7M in H1 FY26 vs $14.3M in H1 FY25, driven by higher purchases of investments and the acquisition.
• · Cash used in financing activities was $51.7M in H1 FY26 vs $24.9M in H1 FY25, including $28.1M in settlements of share-based awards.
• · The effective tax rate for H1 FY26 was 17.6% vs 11.6% in H1 FY25, with the prior period benefiting from a $5.8M tax benefit related to stock compensation.
• · Provision for income taxes was $13.6M in Q2 FY26 vs $0.4M in Q2 FY25, a significant increase due to the prior year's tax benefit.

02-09-2026

Attovia Therapeutics reported its quarterly results for the period ended June 30, 2026. The company generated $450,000 in collaboration revenue for both the three and six-month periods ended June 30, 2026, compared to zero revenue in the same periods of 2025. However, net loss attributable to common stockholders widened to $20.7 million in Q2 2026 from $14.4 million in Q2 2025, and total cash, cash equivalents, and restricted cash decreased to $33.2 million as of June 30, 2026 from $43.0 million a year earlier. Research and development expenses rose 39% year-over-year for both the quarter and six-month period.

• · General and administrative expenses for H1 2026 decreased to $6.5M from $7.3M in H1 2025.
• · Interest income fell to $1.1M in Q2 2026 from $2.0M in Q2 2025.
• · Net cash used in operating activities for H1 2026 was $34.9M, up from $26.7M in H1 2025.
• · The company had a stockholders' deficit of $145.5M at June 30, 2026, compared to $107.4M at December 31, 2025.
• · Weighted-average shares outstanding increased 8.8% in Q2 2026 vs Q2 2025.

02-09-2026

Cisco reported strong fiscal 2026 results with total revenue of $63,325M, up 12% YoY, driven by 16% growth in product revenue to $48,295M. Net income surged 30% to $13,267M and diluted EPS rose 31% to $3.33. However, services revenue was flat at $15,030M (down slightly from $15,046M), gross margin declined 0.4 points to 64.5%, and inventories more than doubled to $5,694M, signaling potential supply chain or demand challenges.

• · Total debt increased to $29,533M from $28,093M in FY2025.
• · Cash and cash equivalents and investments decreased slightly to $15,918M from $16,110M.
• · Cash provided by operating activities was nearly flat at $14,177M vs $14,193M.
• · Stock repurchases increased to $6,106M from $5,995M; dividends paid rose to $6,553M from $6,437M.
• · Restructuring and other charges in Q4 FY2026 were $511M vs $35M in Q4 FY2025 (not meaningful comparison).
• · Income tax percentage increased to 17.1% in FY2026 from 8.3% in FY2025, a significant rise of 8.8 points.

02-09-2026

PVH Corp. reported a net loss of $102.9M for Q2 FY26 (13 weeks ended August 2, 2026), swinging from net income of $224.2M in the same quarter last year, primarily due to a $439.0M goodwill and intangible asset impairment. Revenue declined 3.2% to $2,097.0M from $2,167.2M, while gross margin improved to 63.0% from 57.7%, driven by lower cost of goods sold. For the first half of FY26, net loss was $14.9M versus net income of $179.4M a year ago, though operating cash flow more than doubled to $336.4M.

• · Goodwill and intangible impairments in Q2 FY26 were $439.0M, down from $479.5M in H1 FY25.
• · Cash and cash equivalents surged to $965.9M from $701.5M at fiscal year-end, a 37.7% increase.
• · Net inventories increased $154.7M to $1,738.2M from $1,583.5M at February 1, 2026.
• · Long-term debt decreased slightly to $2,236.5M from $2,291.4M.
• · The company received $37.7M from the sale of a warehouse and distribution center.

02-09-2026

Netskope Inc. reported a 29.2% YoY revenue increase to $220.5M for Q2 FY26 (three months ended July 31, 2026), with gross profit up 32.3% to $163.0M. However, operating losses widened significantly to $89.8M (vs. $46.0M in Q2 FY25) and net loss increased to $110.8M from $90.3M, driven by a surge in sales & marketing and R&D expenses. Cash and cash equivalents fell sharply from $432.6M to $220.9M, and operating cash flow turned negative at -$70.5M for the six-month period, compared to positive $8.7M a year ago.

• · Sales and marketing expenses rose 35.7% YoY to $105.9M in Q2 FY26.
• · Research and development expenses increased 39.7% YoY to $101.8M in Q2 FY26.
• · General and administrative expenses surged 146.5% YoY to $45.1M in Q2 FY26.
• · Deferred revenue (current) grew 2.6% to $546.5M from $532.7M since January 31, 2026.
• · Convertible notes decreased slightly from $721.0M to $698.1M.
• · Accumulated deficit widened to $2.856B from $2.629B.
• · Weighted-average shares used in net loss per share calculation increased from 108.1M to 405.0M (Q2 YoY), reflecting significant equity issuance.

02-09-2026

B&R Technology Merger Corp. filed its 10-Q for the quarter ended June 30, 2026, reporting total assets of $317,458 and a net loss of $70,443 for the three-month period and $82,690 for the six-month period. The company had no revenue and its accumulated deficit grew from $6,864 at year-end 2025 to $89,554, while total liabilities increased to $382,012 from $17,194. The company is a pre-revenue SPAC with no Class A shares outstanding and a shareholder deficit of $64,554.

• · The company had no Class A Ordinary Shares issued or outstanding as of June 30, 2026.
• · General and administrative costs were $70,456 for the three months and $82,705 for the six months ended June 30, 2026.
• · Interest income was only $13 for the three months and $15 for the six months.
• · Net cash used in operating activities was $94,642 for the six months ended June 30, 2026.
• · Net cash provided by financing activities was $121,455, primarily from proceeds from the IPO Note ($225,290) and advances from related party ($74,816).
• · Deferred offering costs of $251,651 were capitalized as of June 30, 2026.
• · The company has a warrant redemption provision triggered if Class A Ordinary Shares price equals or exceeds $18.00 for 20 trading days within a 30-day period.

02-09-2026

MYX Inc. filed its annual 10-K for the fiscal year ended May 31, 2026, reporting net income of $14,628 on revenue of $38,104, a significant turnaround from the prior year's accumulated deficit of $99,083. The company generated $72,100 in cash from operations, ending the period with $34,500 in cash, compared to zero at the start. However, total liabilities rose to $110,100 from $57,416, and the company still carries an accumulated deficit of $84,455, with management noting a going concern assumption and reliance on raising additional funds.

• · Revenue of $38,104 was entirely gross profit, with zero cost of revenue reported.
• · Operating expenses were $23,476, all classified as general and administrative.
• · Net income per share (basic and diluted) was $0.0029.
• · Equipment net book value was $8,867 after accumulated depreciation of $6,333.
• · Intangible assets decreased from $32,400 to $27,778, reflecting amortization of $12,222.
• · Depreciation expense was $5,067.
• · Short-term loans from shareholder of $3,109 were taken during the period.
• · Prepaid research costs of $30,000 and capitalized software platform costs of $7,600 were incurred as investing activities.
• · No financing activities occurred during the period.
• · The company has a full valuation allowance against deferred tax assets due to historical losses.
• · Management assumes a going concern but acknowledges reliance on raising additional funds.

02-09-2026

Daktronics reported net sales of $234.6M for Q1 FY27 (three months ended August 1, 2026), up 7.1% from $219.0M in the prior-year quarter. Net income rose 18.0% to $19.4M from $16.5M, with diluted EPS increasing to $0.40 from $0.33. However, the company faced a cumulative translation loss of $(197K) versus a gain of $279K a year ago, and treasury stock repurchases increased to $4.4M from $10.7M, reducing share count. Operating cash flow improved to $31.4M from $26.1M, while total assets grew to $607.4M from $554.4M.

• · Gross profit margin improved to 30.5% ($71.6M) from 29.7% ($65.1M) YoY.
• · Operating expenses increased 11.6% to $46.7M from $41.8M, driven by higher selling, G&A, and R&D costs.
• · Interest income (net) rose to $1.1M from $0.9M.
• · Other expense (net) improved to $(0.4M) from $(1.9M).
• · Income tax expense increased to $6.2M from $5.8M.
• · Total assets grew 9.6% to $607.4M from $554.4M, driven by higher cash, receivables, and inventories.
• · Total liabilities increased to $289.8M from $253.7M, mainly due to higher accounts payable and contract liabilities.
• · Stockholders' equity rose to $317.6M from $300.7M.
• · Share repurchases slowed to $4.4M in Q1 FY27 from $10.7M in Q1 FY26.
• · Depreciation and amortization was $4.7M, nearly flat YoY.

02-09-2026

Provident Financial Holdings reported its annual results for the year ended June 30, 2026, showing a modest improvement in net interest income to $36.3M (up 2.4% from $35.5M) driven by a wider interest rate spread of 2.91% (vs. 2.74%). Asset quality improved significantly, with non-performing loans falling 64% to $505K (0.05% of loans) from $1.4M (0.14%) and total classified assets halving to $2.5M (0.20% of assets) from $5.0M (0.40%). However, total interest-earning assets declined 2.9% to $1.18B, and net interest income growth was modest, while total assets also shrank 2.8% to $1.21B.

• · Total special mention loans decreased to $792K (2 loans) from $1.1M (2 loans) a year earlier.
• · Substandard loans fell to $1.7M (5 loans) from $3.9M (12 loans), a 57% decline in balance and 58% drop in count.
• · Interest income on loans receivable decreased $519K to $52.0M, driven by lower average balances (-$763K volume effect) partially offset by higher rates (+$247K rate effect).
• · Interest expense on borrowings fell $2.2M to $7.7M, reflecting lower average borrowings ($180M vs $216M) and a lower average cost (4.30% vs 4.59%).
• · Total interest expense on interest-bearing liabilities decreased $1.6M to $19.6M, primarily due to lower borrowing costs.
• · Average stockholders' equity declined slightly to $128.8M from $130.7M.
• · The ratio of average interest-earning assets to average interest-bearing liabilities improved to 110.61% from 110.38%.